Mark Rupp, MD
Infectious Disease · Omaha, NENPI 1821045154
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (38.6%), consulting fees and education — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Teleflex LLC at 56.7% of the total. Among infectious disease clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 52 payments — averaging $1463.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$43K
- KCI USA, Inc.$27K
- Bard Access Systems, Inc.$5K
- BD$320
- Teleflex Medical Canada Inc.$122
- Astellas Pharma US Inc$110
- plus $13 from 1 others
What the payments were for
- Consulting fees$24,00132%
- Speaking & faculty fees$29,37539%
- Travel & lodging$7,55710%
- Food & beverage$3690%
- Education$14,82319%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 36 | $43,154 |
| KCI USA, Inc. | 7 | $27,200 |
| Bard Access Systems, Inc. | 4 | $5,206 |
| BD | 1 | $320 |
| Teleflex Medical Canada Inc. | 1 | $122 |
| Astellas Pharma US Inc | 2 | $110 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tegaderm$25,700
- Arrow$21,804
- CATHETERS - ARROW$13,050
- CVC (AGB+)$6,525
- 3M Cavilon$5,500
- Comply$2,750
- STERI-DRAPE IOBAN 2 SPECIALTY DRAPES$1,500
- MIDLINE (AGB-A)$1,350
- CVC - Arrow$136
How this compares
$76,125 in reported general payments places this provider in the 95th percentile of 55 infectious disease providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Omaha
- Rudolf KotulaOmaha$221K
- Marvin BittnerOmaha$100K
- Trevor VanschooneveldOmaha$56K
- Nada FadulOmaha$26K
- Alison FreifeldOmaha$15K
- Amir GholamiOmaha$12K
- Andre KalilOmaha$11K
- Kelly CawcuttOmaha$11K
- Diana FlorescuOmaha$11K
- Jeffrey SartinOmaha$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.